Abstract: Non-limiting examples of the present disclosure describe electronic document generation, where an electronic document of an application/service may be dynamically generated in a manner that is tailored specifically for a user. A query may be received that comprises a topic for generation of a slide-based visual presentation. The query is processed. In some examples, slide content suggestions may be generated and presented to a user based on the query processing. Content for a processed query may be retrieved by a plurality of data service providers that are connected with the visual presentation service via a distributed network. An electronic document may be generated for the slide-based visual presentation. The electronic document is specifically tailored for a user and dynamically generated based on one or more of: the processing of the query, the retrieved content, a selection of one or more slide content suggestions and an evaluation of signal data associated with the user.

Abstract: The present invention relates to compositions and methods for treatment of proliferative disease. In specific aspects, the present invention relates to compositions including celecoxib and plumbagin in combination; methods for treatment of a proliferative disease including administration of celecoxib and plumbagin in a subject in need thereof; and particularly methods for treatment of skin cancer including administration of celecoxib and plumbagin in a subject in need thereof.

Abstract: Pharmaceutical compositions of tenecteplase that are safe and effective in the treatment of acute ischemic stroke compared with the known compositions are disclosed. The compositions of the invention are invented based on a series of testing trials on the different amounts of the TNK and isolating specific amount that is optimally suitable in terms of desired effects of TNK in the treatment of acute ischemic stroke.

Abstract: The vagus nerve and branches of the vagus nerve are stimulated below the laryngeal nerve branch bifurcation in order to induce desired parasympathetic responses, such as decreased heart rate, without also triggering any adverse sympathetic responses. Stimulating surfaces of an open field bipolar electrode are positioned on or inserted through the pleural membrane overlying the vagus nerve at a location having substantially no cardiac sympathetic fibers adjacent to the vagus nerve. The open field bipolar electrodes can be securable-wire, needle, plate, or any other type of electrode suitable for being secured to the pleural membrane using one or more fastening mechanisms. Electrical stimuli are generated by a stimulator connected to the stimulating surfaces of the open field bipolar electrode by one or more leads.

Abstract: The present invention provides a novel, scalable and industrially viable downstream process for purification of recombinant human G-CSF.

Abstract: Pharmaceutical compositions of tenecteplase that are safe and effective in the treatment of acute ischemic stroke compared with the known compositions are disclosed. The compositions of the invention are invented based on a series of testing trials on the different amounts of the TNK and isolating specific amount that is optimally suitable in terms of desired effects of TNK in the treatment of acute ischemic stroke.

Abstract: A system and method of exposing debugging information in a graphical modeling and execution environment is disclosed. The present invention allows a user to view debugging information in the same window as the graphical view of the model being executed. Debugging data is associated with relevant components of the model displayed in the graphical view. A separate execution list view shows the methods called during the execution of the block diagram in the current time step up until the current point in execution. User-set breakpoints and conditional breakpoints may be set in both the model view and the execution list view. Values may be obtained for all of the displayed methods. The debugging tool may be implemented by using it in conjunction with a graphical modeling and execution environment, such as a block diagram environment or state diagram environment.

Abstract: A device receives information that identifies a parameter associated with a masked block that represents elements of a block diagram model that, when executed, simulates a behavior of a system. The masked block is associated with a first user interface that allows a value of the parameter to be specified for the masked block. The device receives an indication that the parameter is to be associated with a derived block that represents the elements of the block diagram model. The derived block inherits one or more properties from the masked block. The device creates the derived block, and associates the derived block with the parameter and a second user interface that allows a value of the parameter to be specified for the derived block. The device outputs or stores information that identifies the parameter, the derived block, and the association between the parameter and the derived block.

Abstract: A device receives variants associated with a model generated in a graphical modeling environment, and determines a hierarchy of the variants based on a hierarchy of the model. The device receives mode information for the variants, where the mode information includes a subset of a number of variant permutations. For each mode, the device receives control variables for the variants and optional constraints for the variants in the mode. The control variables define which variants are active, and the optional constraints ensure modeling correctness by enabling identification of conflicts between the variants. The device generates a variant manager tool based on the hierarchy of the variants, the mode information, the control variables, and the optional constraints, and outputs or stores variant information via the variant manager tool.

Abstract: The present invention relates to compositions and methods for treatment of proliferative disease. In specific aspects, the present invention relates to compositions including celecoxib and plumbagin in combination; methods for treatment of a proliferative disease including administration of celecoxib and plumbagin in a subject in need thereof; and particularly methods for treatment of skin cancer including administration of celecoxib and plumbagin in a subject in need thereof.

Abstract: A system and method of exposing debugging information in a graphical modeling and execution environment is disclosed. The present invention allows a user to view debugging information in the same window as the graphical view of the model being executed. Debugging data is associated with relevant components of the model displayed in the graphical view. A separate execution list view shows the methods called during the execution of the block diagram in the current time step up until the current point in execution. User-set breakpoints and conditional breakpoints may be set in both the model view and the execution list view. Values may be obtained for all of the displayed methods. The debugging tool may be implemented by using it in conjunction with a graphical modeling and execution environment, such as a block diagram environment or state diagram environment.

Abstract: A computational device receives, from a user, a selection of a block, a subsystem or multiple blocks from a block diagram modeling environment, and presents, to the user, a set of parameters associated with the block, subsystem, or multiple blocks. The computational device receives, from the user, selection of a first subset of parameters from the set of parameters, and creates a customized dialog box by promoting the selected first subset of parameters to the customized dialog box, wherein the customized dialog box permits editing of values associated only with the first subset of parameters.

Abstract: A system includes an application server that hosts a plurality of enterprise applications and stores enterprise data associated with each of the enterprise applications. A client device executes a client application that can provide access to each of the enterprise applications. The client application includes a memory protection engine that allocates a first memory location for the enterprise data transmitted to the client device so the enterprise data is accessible to each of the plurality of enterprise applications through the client application. A second allocated memory location is allocated for non-enterprise data. A mobile enterprise server transmits the enterprise data to the client device.

Abstract: A system includes an application server that hosts a plurality of enterprise applications and stores enterprise data associated with each of the enterprise applications. A client device executes a client application that can provide access to each of the enterprise applications. The client application includes a memory protection engine that allocates a first memory location for the enterprise data transmitted to the client device so the enterprise data is accessible to each of the plurality of enterprise applications through the client application. A second allocated memory location is allocated for non-enterprise data. A mobile enterprise server transmits the enterprise data to the client device.

Abstract: An administrator selects a representation of a logical server on a display. The logical server is stored in a logical-server database. The logical-server database stores logical-servers and specifies their resource requirements and network identities. The logical servers are deployable to physical and/or virtual real servers. A logical-server manager program responds to the selection by displaying a warning symbol. The administrator interacts with the warning symbol, and the logical-server manager program responds by displaying a message specifying that the real server is unsuitable or impaired as a host for deployment of the logical server.

Abstract: Pharmaceutical compositions of tenecteplase that are safe and effective in the treatment of acute ischemic stroke compared with the known compositions are disclosed. The compositions of the invention are invented based on a series of testing trials on the different amounts of the TNK and isolating specific amount that is optimally suitable in terms of desired effects of TNK in the treatment of acute ischemic stroke.

Abstract: A computer implemented approach to facilitate multi-phase bid evaluation. In one embodiment, a digital processing system receives information packets (corresponding to bids) from different suppliers containing information elements associated with one of a sequence of phases. On receiving an indication (from a buyer) that a specific phase of the bidding is to be evaluated starting at a time instance, the system allows the buyer access of elements associated with the specific phase only after the time instance, while allowing access to elements associated with a previous phase (occurring prior to the specific phase in the sequence of phases) even before the time instance. In a scenario where the suppliers who have successfully qualified in the previous phase are received, the system allows access of elements associated with the specific phase corresponding only to the qualified suppliers in response to the indication.

Abstract: A computational device receives, from a user, a selection of a block, a subsystem or multiple blocks from a block diagram modeling environment, and presents, to the user, a set of parameters associated with the block, subsystem, or multiple blocks. The computational device receives, from the user, selection of a first subset of parameters from the set of parameters, and creates a customized dialog box by promoting the selected first subset of parameters to the customized dialog box, wherein the customized dialog box permits editing of values associated only with the first subset of parameters.

Abstract: A system and method of exposing debugging information in a graphical modeling and execution environment is disclosed. The present invention allows a user to view debugging information in the same window as the graphical view of the model being executed. Debugging data is associated with relevant components of the model displayed in the graphical view. A separate execution list view shows the methods called during the execution of the block diagram in the current time step up until the current point in execution. User-set breakpoints and conditional breakpoints may be set in both the model view and the execution list view. Values may be obtained for all of the displayed methods. The debugging tool may be implemented by using it in conjunction with a graphical modeling and execution environment, such as a block diagram environment or state diagram environment.

Abstract: In a graphical modeling environment, one of a selection of transformation operations is performed on a graphical object by first selecting the graphical object. A user may select a particular transformation operation to be executed on the graphical object from a list of transformation operations displayed to the user. A transformed graphical object derived from the selected graphical object may be then automatically created without retrieving the transformed graphical object from a library or other source.